Gregory W. Adams

Array ( [id] => 6543748 [patent_doc_number] => 20100016211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'Treatment of Melanoma With Alpha Thymosin Peptides' [patent_app_type] => utility [patent_app_number] => 12/501829 [patent_app_country] => US [patent_app_date] => 2009-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4787 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016211.pdf [firstpage_image] =>[orig_patent_app_number] => 12501829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6576606 [patent_doc_number] => 20100047239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'Dual variable domain immunoglobulin and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/459624 [patent_app_country] => US [patent_app_date] => 2009-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 56838 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047239.pdf [firstpage_image] =>[orig_patent_app_number] => 12459624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6544035 [patent_doc_number] => 20100016228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'TRUNCATED BARD1 PROTEIN, AND ITS DIAGNOSTIC AND THERAPEUTIC USES' [patent_app_type] => utility [patent_app_number] => 12/489893 [patent_app_country] => US [patent_app_date] => 2009-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6212 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016228.pdf [firstpage_image] =>[orig_patent_app_number] => 12489893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6135099 [patent_doc_number] => 20110008840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'ANTI-CD33 ANTIBODIES AND METHODS FOR TREATMENT OF ACUTE MYELOID LEUKEMIA USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/483543 [patent_app_country] => US [patent_app_date] => 2009-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 18373 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008840.pdf [firstpage_image] =>[orig_patent_app_number] => 12483543 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6472483 [patent_doc_number] => 20100041096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'Carcinostatic method using BRCA1-BARD1 pathway' [patent_app_type] => utility [patent_app_number] => 12/453723 [patent_app_country] => US [patent_app_date] => 2009-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9162 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041096.pdf [firstpage_image] =>[orig_patent_app_number] => 12453723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8152426 [patent_doc_number] => 08168755 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-01 [patent_title] => 'Antibodies specific to heterodimers of Bcl-2 family and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/437127 [patent_app_country] => US [patent_app_date] => 2009-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 5 [patent_no_of_words] => 6266 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/168/08168755.pdf [firstpage_image] =>[orig_patent_app_number] => 12437127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5558744 [patent_doc_number] => 20090270321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'Over-expression of MPS-1 gene or its gene product(s) results in reduction in size of a variety of malignancies' [patent_app_type] => utility [patent_app_number] => 12/384962 [patent_app_country] => US [patent_app_date] => 2009-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5374 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270321.pdf [firstpage_image] =>[orig_patent_app_number] => 12384962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5304387 [patent_doc_number] => 20090299039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'ANTI-A33 ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/421431 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 34386 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20090299039.pdf [firstpage_image] =>[orig_patent_app_number] => 12421431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5464413 [patent_doc_number] => 20090324613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'Compositions and Methods for the Therapy and Diagnosis of Cytomegalovirus' [patent_app_type] => utility [patent_app_number] => 12/401585 [patent_app_country] => US [patent_app_date] => 2009-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 35520 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20090324613.pdf [firstpage_image] =>[orig_patent_app_number] => 12401585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4520989 [patent_doc_number] => 07951369 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-31 [patent_title] => 'Chimeric, human and humanized anti-granulocyte antibodies and methods of use' [patent_app_type] => utility [patent_app_number] => 12/398416 [patent_app_country] => US [patent_app_date] => 2009-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 39164 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/951/07951369.pdf [firstpage_image] =>[orig_patent_app_number] => 12398416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8201540 [patent_doc_number] => 08188233 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-29 [patent_title] => '1B20 PCSK9 antagonists' [patent_app_type] => utility [patent_app_number] => 12/322861 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 31136 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/188/08188233.pdf [firstpage_image] =>[orig_patent_app_number] => 12322861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8201551 [patent_doc_number] => 08188234 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-29 [patent_title] => '1D05 PCSK9 antagonists' [patent_app_type] => utility [patent_app_number] => 12/322867 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 32683 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/188/08188234.pdf [firstpage_image] =>[orig_patent_app_number] => 12322867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6343373 [patent_doc_number] => 20100330078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'ALPHA 5 - BETA 1 ANTIBODIES AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 12/365638 [patent_app_country] => US [patent_app_date] => 2009-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 37379 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330078.pdf [firstpage_image] =>[orig_patent_app_number] => 12365638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5379383 [patent_doc_number] => 20090191222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'Metastatic human tumor associated molecule, methods to detect both activated gene and protein and to interfere with gene expression' [patent_app_type] => utility [patent_app_number] => 12/321821 [patent_app_country] => US [patent_app_date] => 2009-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6992 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191222.pdf [firstpage_image] =>[orig_patent_app_number] => 12321821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5385197 [patent_doc_number] => 20090226442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'RON antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/320296 [patent_app_country] => US [patent_app_date] => 2009-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 67102 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20090226442.pdf [firstpage_image] =>[orig_patent_app_number] => 12320296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5379280 [patent_doc_number] => 20090191119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'CANCEROUS DISEASE MODIFYING ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/357012 [patent_app_country] => US [patent_app_date] => 2009-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13375 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191119.pdf [firstpage_image] =>[orig_patent_app_number] => 12357012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6528761 [patent_doc_number] => 20100015148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE UTILIZATION AND TARGETING OF OSTEOMIMICRY' [patent_app_type] => utility [patent_app_number] => 12/343063 [patent_app_country] => US [patent_app_date] => 2008-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 25674 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20100015148.pdf [firstpage_image] =>[orig_patent_app_number] => 12343063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5479613 [patent_doc_number] => 20090202570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'PM-2 ANTIBODIES, FUNCTIONAL FRAGMENTS AND METHODS FOR TREATING METASTASIS' [patent_app_type] => utility [patent_app_number] => 12/339737 [patent_app_country] => US [patent_app_date] => 2008-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 37633 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202570.pdf [firstpage_image] =>[orig_patent_app_number] => 12339737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4596481 [patent_doc_number] => 07982017 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-19 [patent_title] => 'Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same' [patent_app_type] => utility [patent_app_number] => 12/338934 [patent_app_country] => US [patent_app_date] => 2008-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 25252 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/982/07982017.pdf [firstpage_image] =>[orig_patent_app_number] => 12338934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5580505 [patent_doc_number] => 20090175851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'BIVALENT, BISPECIFIC ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/332531 [patent_app_country] => US [patent_app_date] => 2008-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11612 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20090175851.pdf [firstpage_image] =>[orig_patent_app_number] => 12332531 [rel_patent_id] =>[rel_patent_doc_number] =>)